Company / Gross Margin
Zimmer Biomet Gross Margin History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
16.4%
FY2019
5-year range
-
FY2016-FY2019
Trend
-2.7%
vs FY2018
Sector context
#93 of 96
Health Care
What the data says
Among 96 Health Care companies, Zimmer Biomet is in the bottom 3% for gross margin. Declined from 16.8% to 16.4% over the past 2 years.
Based on SEC 10-K filings.
16.4% in FY2019 with a 3-year CAGR of -7.9%.
Declined from 16.8% to 16.4% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -7.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 96This company 16.4% Sector average 53.6%
▼
-69.4% below sector average
Key checks
Key Insights
- In FY2019, gross margin decreased 2.7% year-over-year.
- Currently 37.2pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | 16.4% | -2.7% |
| FY2018 | 16.8% | +0.1% |
| FY2017 | 16.8% | -30.9% |
| FY2016 | 24.3% | +76.0% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026